Oldest pages
Appearance
Showing below up to 50 results in range #51 to #100.
- Publication: A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation (07:23, 27 June 2024)
- Publication: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients (09:25, 27 June 2024)
- Publication: Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy (10:53, 27 June 2024)
- Publication: Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer (11:35, 27 June 2024)
- Publication: β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial (08:47, 30 June 2024)
- Publication: Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial (11:03, 1 July 2024)
- Publication: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study (10:32, 2 July 2024)
- Publication: EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer (07:35, 3 July 2024)
- Publication: A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients (11:34, 4 July 2024)
- Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (14:26, 4 July 2024)
- Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (13:49, 5 July 2024)
- Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (13:53, 5 July 2024)
- Publication: Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer (13:54, 5 July 2024)
- Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (13:55, 5 July 2024)
- Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (13:58, 5 July 2024)
- Publication: Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (13:59, 5 July 2024)
- Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (14:00, 5 July 2024)
- Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (14:03, 5 July 2024)
- Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (14:03, 5 July 2024)
- Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (14:04, 5 July 2024)
- Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (13:19, 6 July 2024)
- Publication: Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy (13:22, 6 July 2024)
- Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (11:46, 8 July 2024)
- Publication: Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy (13:18, 8 July 2024)
- Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (06:27, 9 July 2024)
- Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (07:22, 9 July 2024)
- Test author (08:27, 9 July 2024)
- Lippman, SM (08:37, 9 July 2024)
- Muecke, R (08:41, 9 July 2024)
- Publication: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (08:46, 9 July 2024)
- Publication: Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients (09:53, 9 July 2024)
- Publication: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients (11:42, 9 July 2024)
- Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (12:02, 9 July 2024)
- Publication: Vitamin E neuroprotection for cisplatin neuropathy (13:06, 9 July 2024)
- Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (13:50, 9 July 2024)
- Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (14:10, 9 July 2024)
- Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (11:30, 10 July 2024)
- Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial (13:59, 10 July 2024)
- Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (08:07, 11 July 2024)
- Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (07:37, 12 July 2024)
- Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer (08:56, 12 July 2024)
- Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (08:51, 15 July 2024)
- Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (09:40, 15 July 2024)
- Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (11:56, 15 July 2024)
- Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (12:29, 15 July 2024)
- Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (13:47, 15 July 2024)
- Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (07:22, 16 July 2024)
- Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial (07:46, 16 July 2024)
- Publication: Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture (09:22, 16 July 2024)
- Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (10:00, 16 July 2024)